P213 Risk factors associated with NAFLD and liver fibrosis in patients with Inflammatory Bowel Disease: a prospective cohort study by Martínez-Domínguez, S J, García Mateo, S, Gallego Llera, B, Gargallo-Puyuelo, C J, Refaie, E, Arroyo Villarino, M T, Laredo de la Torre, V, Alfambra Cabrejas, E, Gomollón García, F

Get full text

P226 Nuclear magnetic resonance spectroscopy measure of protein glycosylation is a biomarker of activity and metabolic complications in Inflammatory Bowel Disease by García Mateo, S, Martínez-Dominguez, S J, Aso Gonzalvo, M C, Refaie, E, Gallego Llera, B, Alfambra Cabrejas, E, Sanz, B, Amigó Grau, N, Ribalta, J, Martínez-Micaelo, N, Gargallo-Puyuelo, C J, Gomollón, F

Get full text

DOP52 Safety of Inflammatory Bowel Disease drugs during pregnancy and breastfeeding: Mothers and babies’ outcomes (DUMBO registry) by Chaparro, M, García Donday, M, Calviño Suarez, C, Rubio, S, Figueira, M, Pérez Martínez, I, Leo Carnerero, E, Rodríguez Lago, I, Ruiz Cerulla, A, Aguas, M, López Serrano, P, Ramírez de la Piscina Urraca, P, Rivero, M, Suarez Ferrer, C, Alfambra Cabrejas, E, Armesto, R, Diz-Lois Palomares, M T, Guerra, I, Vázquez Morón, J M, Casanova, M J, Hervías Cruz, D, Huguet, J M, de Jorge Turrión, M Á, Marín Pedrosa, S, Molina Arriero, G, Ramos, L, Zúñiga de Mora-Figueroa, B, Camargo Camero, R, Fernández-Clotet, A, Gutiérrez Casbas, A, Martínez Montiel, P, Rodríguez Insa, R, Sendra Rumbeu, P, Tardillo Marín, C, Vicente Lidón, R, Arias García, L, Bujanda, L, Lucendo, A J, Manceñido Marcos, N, Gisbert, J P

Get full text